Skip to content

Tirzepatide studies: 457 papers with results

Page 4 of 10

  1. Effect of Tirzepatide on Heart Failure in Type 2 Diabetes Mellitus and Obesity: A Systematic Review and Meta-Analysis.

    He YM · Diabetes/metabolism research and reviews · 2025

    Systematic review · 6 results

  2. Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A meta-analysis.

    Gong J · Journal of diabetes investigation · 2025

    Systematic review · 4 results

  3. A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile acceptable?

    Meng Z · Frontiers in endocrinology · 2023

    Systematic review · 13 results

  4. Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta-analysis.

    Karakasis P · Diabetes, obesity & metabolism · 2024

    Systematic review · 6 results

  5. Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.

    Aminorroaya A · Journal of the American College of Cardiology · 2025

    Systematic review · 6 results

  6. Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis.

    Guan R · Frontiers in pharmacology · 2022

    Systematic review · 7 results

  7. The effects of subcutaneous Tirzepatide on obesity and overweight: a systematic review and meta-regression analysis of randomized controlled trials.

    Rohani P · Frontiers in endocrinology · 2023

    Systematic review · 4 results

  8. Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials.

    Mansouri ES · Journal of the American Heart Association · 2026

    Systematic review · 3 results

  9. Tirzepatide for adults living with obesity.

    Franco JV · The Cochrane database of systematic reviews · 2025

    Systematic review · 16 results

  10. Exploring the Efficacy and Safety of Tirzepatide in Obesity Management and Cardiometabolic Risk Factors: A Comprehensive Systematic Review and Meta-Analysis.

    Wang JY · Clinical obesity · 2025

    Systematic review · 10 results

  11. Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis including the latest SURMOUNT-2 trial.

    Qin W · Endocrine · 2024

    Systematic review · 13 results

  12. Effects of tirzepatide on weight management in patients with and without diabetes: a systematic review and meta-analysis.

    Cerchi E · International journal of obesity (2005) · 2025

    Systematic review · 14 results

  13. Tirzepatide outcompetes long-acting insulin in managing type 2 diabetes: a meta-analysis of three phase 3 randomized controlled trials.

    Ala M · International journal of obesity (2005) · 2024

    Systematic review · 13 results

  14. Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials.

    Liu L · International journal of clinical pharmacy · 2024

    Systematic review · 8 results

  15. Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety.

    Müllertz ALO · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024

    Systematic review · 6 results

  16. Effects of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

    Kanbay M · Diabetes, obesity & metabolism · 2026

    Systematic review · 2 results

  17. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.

    Yao H · BMJ (Clinical research ed.) · 2024

    Systematic review · 11 results

  18. Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.

    Shi Q · BMJ (Clinical research ed.) · 2023

    Systematic review · 3 results

  19. Anti-diabetic drugs and weight loss in patients with type 2 diabetes.

    Lazzaroni E · Pharmacological research · 2021

    Systematic review · 3 results

  20. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.

    Karakasis P · Metabolism: clinical and experimental · 2025

    Systematic review · 23 results

  21. Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis.

    Souza M · Hepatology (Baltimore, Md.) · 2025

    Systematic review · 9 results

  22. Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis.

    Stefanou MI · European stroke journal · 2024

    Systematic review · 5 results

  23. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.

    Drake T · Annals of internal medicine · 2024

    Systematic review · 1 result

  24. Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.

    Ismaiel A · International journal of obesity (2005) · 2025

    Systematic review · 19 results

  25. Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials.

    Cai W · Frontiers in public health · 2024

    Systematic review · 17 results

  26. Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials.

    Kanbay M · Diabetes, obesity & metabolism · 2023

    Systematic review · 9 results

  27. Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.

    Xie Z · Frontiers in endocrinology · 2023

    Systematic review · 15 results

  28. Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis.

    Li M · Sleep · 2025

    Systematic review · 20 results

  29. Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis.

    Xie X · Frontiers in pharmacology · 2025

    Systematic review · 9 results

  30. Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials.

    Guo H · Obesity pillars · 2025

    Systematic review · 18 results

  31. Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes.

    Zaazouee MS · Diabetes & metabolic syndrome · 2022

    Systematic review · 8 results

  32. Efficacy and safety of tirzepatide as novel treatment for type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials.

    Permana H · Diabetes & metabolic syndrome · 2022

    Systematic review · 6 results

  33. Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis.

    Nong K · BMJ (Clinical research ed.) · 2025

    Systematic review · 6 results

  34. Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review.

    Stretton B · Internal medicine journal · 2023

    Systematic review · 4 results

  35. A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy-A Systematic Review and Meta-Analysis.

    Salmen T · International journal of molecular sciences · 2023

    Systematic review · 1 result

  36. Efficacy of GLP-1 Receptor Agonist-Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta-Analysis of Randomized Controlled Trials.

    Yin Y · Journal of diabetes · 2025

    Systematic review · 14 results

  37. Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus.

    Tsukamoto S · Diabetes, obesity & metabolism · 2024

    Systematic review · 7 results

  38. Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo-controlled clinical trials.

    Kang YM · Diabetes, obesity & metabolism · 2025

    Systematic review · 1 result

  39. Optimal dose of tirzepatide for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis.

    Yu Y · Frontiers in cardiovascular medicine · 2022

    Systematic review · 20 results

  40. GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis.

    Tan YW · Langenbeck's archives of surgery · 2025

    Systematic review · 13 results

  41. Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis.

    Ren X · Scientific reports · 2025

    Systematic review · 29 results

  42. Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis.

    Karimi MA · Frontiers in pharmacology · 2025

    Systematic review · 26 results

  43. Comparison of the effectiveness and safety of GLP-1 receptor agonists for type 2 diabetes mellitus patients with overweight/obesity: A systematic review and network meta-analysis.

    Wen Z · Diabetes research and clinical practice · 2025

    Systematic review · 8 results

  44. Impact of a dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta-analysis.

    Yang Y · Diabetes, obesity & metabolism · 2024

    Systematic review · 11 results

  45. GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials.

    Ahmad N · Medicine · 2026

    Systematic review · 4 results

  46. Gastrointestinal adverse events of tirzepatide in the treatment of type 2 diabetes mellitus: A meta-analysis and trials sequential analysis.

    Tong K · Medicine · 2023

    Systematic review · 21 results

  47. Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence.

    Parizad R · Vascular health and risk management · 2026

    Systematic review · 8 results

  48. Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP-1 Receptor Agonists: A Network Meta-Analysis of Randomized Controlled Trials.

    Sabatella L · Obesity (Silver Spring, Md.) · 2026

    Systematic review · 10 results

  49. Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis.

    Lin PY · Biomolecules · 2025

    Systematic review · 2 results

  50. Effect of the Dual Glucose‐Dependent Insulinotropic Peptide/Gulcagon‐like Peptide 1 Receptor Agonist Tirzepatide on Lipid Profile and Waist Circumference: A Systematic Review and Meta‐analysis

    Yu D · Clinical therapeutics · 2023

    Systematic review · 7 results

How PepBank reports evidence